Press Release

Morrison & Foerster Lawyer and Biotech Pioneer Named AAAS Fellow

Dr. Kate Murashige honored for outstanding contributions to IP law

01 Dec 2015

WASHINGTON, D.C. (December 1, 2015) – Morrison & Foerster senior of counsel Dr. Kate Murashige, a recognized pioneer in the biotechnology industry, has been named a fellow of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society. AAAS fellows are elected to honor their efforts to advance science or its applications. As part of the chemistry section, Dr. Murashige was elected by her peers for her outstanding contributions to intellectual property law that have helped create and sustain the American biotechnology industry.

“Kate’s groundbreaking and ongoing accomplishments in the biotechnology space are remarkable,” said Michael Ward, chair of Morrison & Foerster’s Patent Practice Group and co-chair of the firm’s Intellectual Property Practice Group. “She was at the forefront in chemistry and biotechnology patent prosecution and counseling, wrote some of the first biotechnology patent applications, and blazed a trail in life sciences. We congratulate her on this well-deserved election.”

Dr. Murashige noted that it was a “great and very much appreciated honor to be elected among such a distinguished group of peers.”

Dr. Murashige, who holds a Ph.D. in biochemistry, was one of the first members of Morrison & Foerster’s Patent Practice Group, which was formed more than two decades ago. She has led a number of noteworthy matters during the course of her career. She prosecuted a bovine growth hormone patent on behalf of the University of California, which took approximately 20 years from application to issuance and resulted in long-term licensing revenue to the university valued at potentially more than $250 million. More recently, she secured blocking patents covering gene silencing using small interfering RNA on behalf of Plant Biosciences Ltd., and she obtained patents to treat Female Sexual Dysfunction using certain technologies on behalf of the Dutch company, Emotional Brain.

New fellows will be recognized February 13, at the AAAS Fellows Forum during the 2016 AAAS Annual Meeting in Washington, D.C.




Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.